TMC Medical Minutes: Cervical Cancer

Posted: Mon 3:51 PM, Sep 08, 2008

Every year, close to 11,000 women in the United States are diagnosed with cervical cancer. Obstetrician and Gynecologist, Dr. Jeffrey Hermann joins us to discuss the importance of getting screened.

Dentist gives back through gift of dental care

Comments are posted from viewers like you and do not always reflect the views of this station.

WebMD Health News

Researchers Learning More About Deadly Pancreatic Cancer

FDA hopes targeted drug research will lead to 'big break'
Some With Kidney Stones Might Have Calcium Buildup in Blood Vessels: Study

These patients might need closer monitoring for further signs of pending heart trouble, researcher says
Flame Retardants May Raise Risk of Preterm Births, Study Finds

Women with higher blood levels of common chemicals were more likely to deliver early
Obama Lifting Curtain on 'Precision Medicine' Plan

President Barack Obama will unveil details Friday about the “Precision Medicine Initiative” – a move toward tailoring and personalizing individual medical treatment.
Colon Cancer Rates Rising Among Americans Under 50

Still, only 10 percent of cases occur in younger group, study finds

AP Top Health Stories

White House: Science indicates parents should vaccinate kids

WASHINGTON (AP) — Amid the measles outbreak stemming from California, the White House is telling parents that science indicates they should vaccinate their children.
POM Wonderful loses bid to tout health benefits in drink ads
Pomegranate juice maker POM Wonderful cannot advertise that its pomegranate drinks treat or prevent heart disease or other ailments unless it has proof, a U.S. appeals court said Friday, upholding an order by the Federal Trade Commission. The U.S. Court of Appeals for the D.C. Circuit largely upheld a 2010 order by the Federal Trade Commission, which found that POM Wonderful's advertising was misleading in claiming its products would treat or reduce the risk of diseases ranging from heart disease to prostate cancer to erectile dysfunction. "Many of those ads mischaracterized the scientific evidence concerning the health benefits of POM's products with regard to those diseases. The FTC Act proscribes — and the First Amendment does not protect — deceptive and misleading advertisements," the court said in its ruling.
Gates Foundation awards $50 million to Stanford vaccine discovery

The Bill & Melinda Gates Foundation said on Friday it had awarded Stanford University a $50 million grant to accelerate vaccine development efforts for the world's most deadly diseases, including AIDS and malaria. The $50 million grant over 10 years will go toward establishing the Stanford Human Systems Immunology Center on the school's California campus, the foundation and university said in a statement. The center will focus research on how the immune system can be harnessed to develop vaccines for the world's most deadly infectious diseases, the university said. Stanford said cost and the amount of time needed for research have been obstacles in developing new vaccinations.
Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday. Sun Pharmaceutical said in April that it had agreed to buy the Indian generic drugmaker from its current owner, Japan's Daiichi Sankyo Co, for $3.2 billion. Ranbaxy has been involved in a wrangle with the U.S. Food and Drug Administration, which has barred a range of its medicines from the United States after finding that some of the company's plants did not meet U.S. standards. The FTC, whose job is to ensure that anti-monopoly laws are enforced, did not weigh in on the safety issue but said it would allow the transaction if Ranbaxy sold its interests in generic minocycline tablets and capsules to generic maker Torrent Pharmaceuticals Ltd, which is also based in India.
Suspected Ebola patient in California tests negative for virus
A California hospital patient who was being tested for Ebola after traveling in West Africa and exhibiting symptoms of the disease has tested negative for infection with the deadly virus, public health and hospital officials said on Friday. The negative test result was disclosed a day after the individual was transferred to a special isolation unit at the University of California-Davis Medical Center, a designated "priority hospital" for potential Ebola cases, from another hospital in Sacramento, the state capital.